Recent Insider Transactions • Jun 19
Independent Director recently bought Mex$1.6m worth of stock On the 15th of June, Jon Marinelli bought around 13k shares on-market at roughly Mex$128 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought Mex$13m more in shares than they have sold in the last 12 months. New Risk • May 16
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$60m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-US$60m free cash flow). Minor Risk Shareholders have been diluted in the past year (25% increase in shares outstanding). Reported Earnings • May 16
First quarter 2026 earnings released: US$0.08 loss per share (vs US$0.005 profit in 1Q 2025) First quarter 2026 results: US$0.08 loss per share (down from US$0.005 profit in 1Q 2025). Revenue: US$6.78m (down 3.1% from 1Q 2025). Net loss: US$11.3m (down US$11.8m from profit in 1Q 2025). Revenue is forecast to grow 34% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Metals and Mining industry in South America. 공시 • May 06
United States Antimony Corporation to Report Q1, 2026 Results on May 14, 2026 United States Antimony Corporation announced that they will report Q1, 2026 results at 4:15 PM, US Eastern Standard Time on May 14, 2026 공시 • Apr 14
United States Antimony Corporation, Annual General Meeting, Jun 12, 2026 United States Antimony Corporation, Annual General Meeting, Jun 12, 2026. New Risk • Mar 24
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$37m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$37m free cash flow). Share price has been highly volatile over the past 3 months (25% average weekly change). Minor Risk Shareholders have been diluted in the past year (25% increase in shares outstanding). Reported Earnings • Mar 21
Full year 2025 earnings released: US$0.035 loss per share (vs US$0.016 loss in FY 2024) Full year 2025 results: US$0.035 loss per share (further deteriorated from US$0.016 loss in FY 2024). Revenue: US$39.3m (up 163% from FY 2024). Net loss: US$4.35m (loss widened 150% from FY 2024). Revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Metals and Mining industry in South America. 공시 • Mar 17
United States Antimony Corporation to Report Fiscal Year 2025 Results on Mar 19, 2026 United States Antimony Corporation announced that they will report fiscal year 2025 results at 4:00 PM, US Eastern Standard Time on Mar 19, 2026 Buy Or Sell Opportunity • Feb 25
Now 37% overvalued after recent price rise Over the last 90 days, the stock has risen 24% to Mex$152. The fair value is estimated to be Mex$111, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 41% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Jan 22
Now 21% overvalued Over the last 90 days, the stock has fallen 16% to Mex$184. The fair value is estimated to be Mex$152, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 41% over the last 3 years. Meanwhile, the company became loss making. 공시 • Nov 26
United States Antimony Corporation Appoints Jon R. Marinelli as Director and Chairman of New Board Committee (Finance Committee), Effective November 24, 2025 On November 24, 2025, upon the recommendation of the Governance and Nominating Committee, the Board of Directors of United States Antimony Corporation ((USAC or US Antimony) appointed Jon R. Marinelli, to serve as a director of the Company, effective immediately November 24, 2025. With Mr. Marinelli’s appointment, the USAC board size increases to seven members, five of which are Independent. Mr. Marinelli has also been appointed Chairman of a new board committee formed on November 24, 2025, the Finance Committee. Mr. Marinelli is a seasoned financial executive and investment professional with more than 25 years of experience in capital markets, M&A, and strategic advisory roles, and has an early-career background in technology. He is the Founder and Principal of 1042 Capital Partners, where he manages public and private investments. Previously, he served as Group Head and Managing Director of U.S. Energy at BMO Capital Markets, and before that held senior roles in Deutsche Bank’s Global Banking–Natural Resources Group, the successor to Bankers Trust. Over his career, Mr. Marinelli has advised on more than $285 billion in M&A, public and private equity, and debt transactions. He holds an MBA from Rice University and a BS from Miami University. Mr. Marinelli will serve until the Company’s next annual meeting of shareholders and until his successor is duly elected and qualified, or until his earlier death, resignation, or removal. On November 25, 2025, US Antimony issued a press release announcing the appointment of Jon R. Marinelli to the Board. Reported Earnings • Nov 13
Third quarter 2025 earnings released: US$0.039 loss per share (vs US$0.006 loss in 3Q 2024) Third quarter 2025 results: US$0.039 loss per share (further deteriorated from US$0.006 loss in 3Q 2024). Revenue: US$8.70m (up 259% from 3Q 2024). Net loss: US$4.78m (loss widened US$4.10m from 3Q 2024). Revenue is forecast to grow 44% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Metals and Mining industry in South America. 공시 • Nov 07
United States Antimony Corporation to Report Q3, 2025 Results on Nov 12, 2025 United States Antimony Corporation announced that they will report Q3, 2025 results at 4:15 PM, US Eastern Standard Time on Nov 12, 2025 공시 • Oct 21
United States Antimony Corporation (NYSEAM:UAMY) proposed to acquire remaining 90% stake in Larvotto Resources Limited (ASX:LRV) for approximately AUD 390 million. United States Antimony Corporation (NYSEAM:UAMY) proposed to acquire remaining 90% stake in Larvotto Resources Limited (ASX:LRV) for approximately AUD 390 million on October 19, 2025. Under the Proposal, Larvotto shareholders would receive Six (6) USAC shares for every One Hundred (100) Larvotto shares. The transaction is subject to the negotiation and execution of a binding scheme implementation deed, Larvotto shareholder approval, regulatory approvals and customary closing conditions. USAC has recently acquired approximately 10.0% of Larvotto’s total issued share capital with cash in the open market which USAC believes makes USAC Larvotto's largest single shareholder.
Jett Capital Advisors, LLC and Henslow Pty. Ltd. acted as financial advisor for United States Antimony Corporation. Ashurst Australia and Duane Morris LLP acted as legal advisor for United States Antimony Corporation. 
